Neuroonkologie
Freie Themen II

Programm

• 09:30 – 09:40 7 Min. 3 Min.

  • Abstractvortrag

  Daily activity, sleep, and neurocognitive functioning under TTFields therapy for glioblastoma in Germany in Routine Clinical Care (TIGER PRO-Active Study)

  • Martin Glas (Essen)
• 09:40 – 09:50 7 Min. 3 Min.

  • Abstractvortrag

  Prognosis and histology of syn- and metachronous meningiomas and comparative analyses with singular lesions

  • Dorothee Spille (Münster)
• 09:50 – 10:00 7 Min. 3 Min.

  • Abstractvortrag

  Pathologic bone mineral density in patients with surgically treated brain metastasis from lung cancer (NSCLC): implications of an unrecognized prognostic factor

  • Anna-Laura Potthoff (Bonn)
• 10:00 – 10:10 7 Min. 3 Min.

  • Abstractvortrag

  Low-dose acetylsalicylic acid treatment in non-skull base meningiomas: Impact on tumor proliferation and seizure burden

  • Johannes Wach (Bonn)
• 10:10 – 10:20 7 Min. 3 Min.

  • Abstractvortrag

  Progressive chronic encapsulated intracerebral hematoma (CEIH) mimicking a neoplastic lesion 10 years after AVM radiosurgery – A case report

  • Susanne Fichte (Erfurt)
• 10:20 – 10:30 7 Min. 3 Min.

  • Abstractvortrag

  Tumorassoziierte Epilepsie in 1 Jahr nach Gehirnoperation und Fahrverbot

  • Diyan Dimov (Bielefeld)